Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
car-t cells targeting mesothelin mesothelin NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
T-Lymphocyte[MeSHID:D013601]
Malignant neoplasm of lung[MeSHID:D008175]
cervical cancer[MeSHID:D002583]		 NA phase 1 unknown
car-t cells targeting mesothelin mesothelin NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]
T-Lymphocyte[MeSHID:D013601]		 NA phase 1 unknown
car-t cells targeting mesothelin mesothelin NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant neoplasm of pancreas[MeSHID:D010190]
Pancreatic carcinoma[MeSHID:C562463]
T-Lymphocyte[MeSHID:D013601]		 NA phase 1/2 unknown
car-t cells targeting mesothelin mesothelin NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
T-Lymphocyte[MeSHID:D013601]
Malignant neoplasm of lung[MeSHID:D008175]
cervical cancer[MeSHID:D002583]		 NA phase 1/2 unknown
car-t cells targeting mesothelin mesothelin NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant neoplasm of pancreas[MeSHID:D010190]
Pancreatic carcinoma[MeSHID:C562463]
T-Lymphocyte[MeSHID:D013601]		 NA phase 1 unknown
car-t cells targeting mesothelin mesothelin NA Clinical trial target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant Neoplasms[MeSHID:D009369]
T-Lymphocyte[MeSHID:D013601]		 NA phase 1/2 unknown
click here to return to the previous page